LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
New Fortress Energy
NFE
YETI Holdings
YETI
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -23.41%2.38M | -7.24%3.09M | 38.66%3.05M | -8.35%12.01M | -44.29%3.38M | 10.73%3.11M | 55.90%3.33M | 4.61%2.2M | 59.86%13.1M | 327.23%6.06M |
Operating revenue | -23.41%2.38M | -7.24%3.09M | 38.66%3.05M | -8.35%12.01M | -44.29%3.38M | 10.73%3.11M | 55.90%3.33M | 4.61%2.2M | 59.86%13.1M | 327.23%6.06M |
Cost of revenue | 40.77%1.17M | 83.58%1.1M | 204.31%1.55M | -2.54%2.8M | 6.17%860K | 7.47%834K | -31.62%597K | 23.19%510K | 77.02%2.87M | 141.43%810K |
Gross profit | -46.98%1.2M | -27.11%1.99M | -11.30%1.5M | -9.98%9.21M | -52.08%2.52M | 11.98%2.27M | 116.49%2.73M | 0.06%1.69M | 55.62%10.23M | 384.79%5.25M |
Operating expense | -2.89%18.55M | -4.70%18.08M | -20.40%18.09M | -29.33%80.51M | -25.85%19.72M | -42.72%19.1M | -29.80%18.97M | -15.73%22.72M | 179.92%113.93M | 185.69%26.6M |
Selling and administrative expenses | -4.12%5.8M | 7.97%6.21M | -26.62%6.61M | -48.60%27.74M | -35.10%6.94M | -62.18%6.05M | -59.73%5.75M | -30.86%9.01M | 291.90%53.98M | 182.21%10.69M |
Research and development costs | -2.33%12.75M | -10.21%11.87M | -16.31%11.47M | -11.98%52.77M | -19.64%12.79M | -24.81%13.06M | 3.70%13.22M | -1.58%13.71M | 122.64%59.95M | 188.08%15.91M |
Operating profit | -3.05%-17.35M | 0.93%-16.09M | 21.13%-16.59M | 31.24%-71.3M | 19.40%-17.21M | 46.26%-16.83M | 36.97%-16.24M | 16.79%-21.03M | -203.86%-103.7M | -159.49%-21.35M |
Net non-operating interest income expense | 334.76%493K | 166.40%249K | 108.89%16K | 75.36%-703K | 128.97%62K | 46.70%-210K | 63.94%-375K | 85.06%-180K | -16.21%-2.85M | -6,276.05%-214K |
Non-operating interest income | -2.93%1.23M | 1.58%1.22M | -12.54%1.12M | 108.63%5.08M | 5.47%1.33M | 21.21%1.26M | --1.2M | --1.28M | 24,230.00%2.43M | --1.26M |
Non-operating interest expense | -50.24%733K | -38.44%969K | -24.39%1.11M | 9.33%5.78M | -14.03%1.27M | 2.58%1.47M | 51.35%1.57M | 21.49%1.46M | 114.44%5.29M | --1.48M |
Other net income (expense) | 139.05%2.02M | 1,061.97%3.42M | -95.99%-4.2M | -108.85%-3.1M | 449.35%4.57M | -139.91%-5.17M | -102.44%-355K | -124.28%-2.15M | 2,214.36%35.04M | -15,809.09%-1.31M |
Gain on sale of security | 134.86%1.2M | 42,100.00%2.1M | -195.88%-2.58M | -105.24%-1.16M | 38.66%3.16M | -142.48%-3.44M | -100.06%-5K | -123.15%-873K | 1,430.05%22.13M | --2.28M |
Special income (charges) | 147.37%820K | 475.71%1.32M | -27.44%-1.62M | -115.04%-1.94M | 139.38%1.41M | -135.62%-1.73M | -105.33%-350K | -125.12%-1.27M | --12.9M | ---3.59M |
-Less:Restructuring and merger&acquisition | -147.37%-820K | -475.71%-1.32M | 27.44%1.62M | 110.61%1.94M | 21.02%-1.41M | 135.62%1.73M | 105.33%350K | 125.12%1.27M | ---18.28M | ---1.79M |
-Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.38M | ---- |
Income before tax | 33.23%-14.83M | 26.79%-12.42M | 11.05%-20.77M | -5.01%-75.11M | 45.03%-12.57M | -18.45%-22.22M | -38.48%-16.97M | -32.38%-23.35M | -87.03%-71.52M | -177.84%-22.87M |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | 33.23%-14.83M | 26.79%-12.42M | 11.05%-20.77M | -5.01%-75.11M | 45.03%-12.57M | -18.45%-22.22M | -38.48%-16.97M | -32.38%-23.35M | -87.03%-71.52M | -177.84%-22.87M |
Net income continuous Operations | 33.23%-14.83M | 26.79%-12.42M | 11.05%-20.77M | -5.01%-75.11M | 45.03%-12.57M | -18.45%-22.22M | -38.48%-16.97M | -32.38%-23.35M | -87.03%-71.52M | -177.84%-22.87M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 33.23%-14.83M | 26.79%-12.42M | 11.05%-20.77M | -5.01%-75.11M | 45.03%-12.57M | -18.45%-22.22M | -38.48%-16.97M | -32.38%-23.35M | -87.03%-71.52M | -177.84%-22.87M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 33.23%-14.83M | 26.79%-12.42M | 11.05%-20.77M | -5.01%-75.11M | 45.03%-12.57M | -18.45%-22.22M | -38.48%-16.97M | -32.38%-23.35M | -87.03%-71.52M | -177.84%-22.87M |
Basic earnings per share | 52.94%-0.08 | 46.15%-0.07 | 26.32%-0.14 | 18.57%-0.57 | 52.63%-0.09 | -6.25%-0.17 | -18.18%-0.13 | 42.42%-0.19 | -108.33%-0.7 | -162.68%-0.19 |
Diluted earnings per share | 52.94%-0.08 | 46.15%-0.07 | 26.32%-0.14 | 18.57%-0.57 | 52.63%-0.09 | -6.25%-0.17 | -18.18%-0.13 | 42.42%-0.19 | -108.33%-0.7 | -162.68%-0.19 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |